bioAffinity Technologies, Inc. — Form 8-K
Filed July 31, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On July 30, 2026, bioAffinity Technologies received notice of delisting or failure to satisfy continued listing rules/standards. The company is transferring its listing. No specific exchange, timeline, or remediation plan is detailed in this 8-K filing stub.
Why this rating
Delisting notice is existential threat to $22.6M public company; threatens market access, liquidity, investor confidence, and stock survival
Extracted items
See more from July 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.